Brian M. Strem - Mar 3, 2023 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Signature
/s/ Robert A. Petitt, Attorney-in-Fact
Stock symbol
KPRX
Transactions as of
Mar 3, 2023
Transactions value $
$59,748
Form type
4
Date filed
3/7/2023, 07:15 PM
Previous filing
Oct 25, 2022
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Award $59.7K +15.6K +118.33% $3.83 28.8K Mar 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 +10.4K $0.00 10.4K Mar 3, 2023 Common Stock 10.4K $3.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of March 3, 2024, March 3, 2025 and March 3, 2026, subject to the reporting person's continuous service through each such vesting date.
F2 The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on March 3, 2024, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.